CTOs on the Move

Advantia Health

www.advantiahealth.com

 
Advantia is transforming healthcare for all women - we`re setting a higher standard of care and convenience while reducing unnecessary costs. Compassion and value inspire everything we do. We take time to listen, answer questions completely, and offer helpful technology between visits so that our patients are empowered and at ease. Alongside coordinated care, Advantia is pioneering care models that align incentives with the best interests of women and their families.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Advantia Health raised $45M on 01/08/2020

Similar Companies

L-Nutra

L-Nutra is a nutri-technology company dedicated to helping people increase their healthspan (healthy years of their lives) through fasting and nutrition with the launch of our first product The Fasting Mimicking Diet.

Unicity International

Unicity International is a Orem, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Toronto Academy of Dentistry

Toronto Academy of Dentistry is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GroupOne Healthsource

GroupOne Healthsource is a Jefferson City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.